DOCSLIB.ORG

Impact of Transforming Viruses on Cellular Mutagenesis, Genome Stability, and Cellular Transformation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Impact of Transforming Viruses on Cellular Mutagenesis, Genome Stability, and Cellular Transformation Environmental and Molecular Mutagenesis 45:304^325 (2005) Review Article Impact of Transforming Viruses on Cellular Mutagenesis, Genome Stability, and Cellular Transformation Michael L.Gatza,1,2 Chandtip Chandhasin,2 Razvan I. Ducu,2 and Susan J. Marriott1,2* 1Interdepartmental Program in Cell and Molecular Biology, Baylor College of Medicine, Houston, Texas 2Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas It is estimated that 15% of all cancers are etiologi- been explicitly linked to the expression of onco- cally linked to viral infection. Specific cancers proteins encoded by these viruses. This review including adult T-cell leukemia, hepatocellular car- discusses mechanisms utilized by these viral onco- cinoma, and uterine cervical cancer are associated proteins, Tax, HBx, and E6/E7, to mediate geno- with infection by human T-cell leukemia virus type I, mic instability and cellular transformation. Environ. hepatitis B virus, and high-risk human papilloma Mol. Mutagen. 45:304–325, 2005. c virus, respectively. In these cancers, genomic 2005 Wiley-Liss, Inc. instability, a hallmark of multistep cancers, has Key words: viral transformation; genomic instability; viral-associated cancer; human T-cell leukemia virus type I; hepatitis B virus; human papilloma virus INTRODUCTION hepatitis B virus (HBV), and human papilloma virus (HPV). These viruses, respectively, are the etiologic The World Health Organization estimates that each agents of adult T-cell leukemia (ATL), hepatocellular car- year approximately 10 million new cancer cases will be cinoma (HCC), and uterine cervical cancer (UCC). reported worldwide and an estimated 6 million people (12% of worldwide deaths) will succumb to some form of this disease (www.who.int/cancer/en). In the United States OVERVIEW OF VIRUSES alone, 2.3 million new cancer cases will be diagnosed and Adult T-Cell Leukemia and HTLV-1 an estimated 556,000 Americans (> 1,500 per day) will die each year from cancer [American Cancer Society, HTLV-1 was the first human oncogenic retrovirus dis- 2003]. Worldwide, it has been estimated that 15% of can- covered [Poiesz et al., 1980] and is now recognized as the cer cases are etiologically linked to viral infection, etiological agent of both ATL and a neurodegenerative accounting for nearly 1.5 million new cases and 900,000 disease, tropical spastic paraparesis/HTLV-1-associated deaths annually [Butel, 2000]. myelopathy (TSP/HAM). HTLV-1 is endemic in parts of Viruses have been etiologically linked to specific forms Japan, South America, Africa, and the Caribbean and is of cancer (Table I), and many other viruses not formally currently estimated to infect nearly 20 million people implicated in human tumorigenesis encode proteins cap- worldwide [Franchini, 1995]. Transmission of this virus able of immortalizing cells in culture and causing tumors in transgenic animals. As in most cancers, cancers asso- *Correspondence to: Susan J. Marriott, Department of Molecular Virol- ciated with these viruses demonstrate gross chromosomal ogy and Microbiology, Baylor College of Medicine, One Baylor Plaza, abnormalities, which have been argued to cause, or at Houston, TX 77030. E-mail: [email protected] least contribute to, cellular transformation and tumor pro- Invited article: 25th anniversary of Environmental and Molecular gression. This review focuses on mechanisms of genomic Mutagenesis instability and cellular transformation mediated by the DOI 10.1002/em.20088 oncoproteins encoded by three well-studied oncogenic Published online 11 January 2005 in Wiley InterScience (www.interscience. viruses: human T-cell leukemia virus type 1 (HTLV-1), wiley.com). c 2005 Wiley-Liss, Inc. Impact of Transforming Viruses 305 ic occurs horizontally through the transfer of body fluids ma rs ease g ithial (i.e., intravenous drug use, blood transfusion, and sexual spast dis n othe ep l thelio T-A bone, ’s known contact) and vertically through the ingestion of milk- SV40 cells, meso borne lymphocytes during breastfeeding [Hino et al., tropica None 5.2 6 Kidney dsDNA Lg/Sm Unknow Brain, ); 1985; Sugiyama et al., 1986; Wiktor et al., 1993; Ferreira Hodgkin et al., 1997]. Due in part to the long latency period (SV40 (BL); (2–4 decades), only 4–5% of the infected population are 40 expected to develop ATL, mostly those who were oma horosis infected as children [Johnson et al., 2001]. Despite the virus cirr an relatively low incidence of ATL, it is a rapidly progres- lymph HCV cytes sing fatal disease that does not respond to any known simi NA C mmon ); rkitt’s treatments and has a mean survival time of 6 months epatitis, epato S3? C u H 9.4 ssR Co 9 H N H B [Jaffe et al., 1984; Shimoyama et al., 1988]. ; (HCV The HTLV-1 genome encodes several proteins that CC) (H virus appear to contribute to infection and oncogenesis. How- C ever, numerous studies have established the viral tran- itis oplakia scriptional transactivator, Tax, as the major viral onco- ithial omas ep leuk carcinoma protein [Grassmann et al., 1992]. Tanaka et al. [1990] hepat V lls ar EB demonstrated that Tax can transform NIH 3T3 and Rat1 lymph hairy B-ce yngeal , l cells and confirmed these observations using mutational D (EBV); ocellul H ora 0 analysis. Later Tax alone, and in combination with Ras, 90 cells, virus IM, 172. dsDNA Common LMP-1 * Orophar BL, hepat was shown to be capable of transforming primary rodent r embryo fibroblasts [Pozzati et al., 1990; Smith and Greene, 1991]. Tax transgenic mice developed neurofibro- (ATL); ein-Bar ital mas and mesenchymal tumors when Tax was ubiquitously Epst emia cells ; expressed in all tissues, but developed primary peripheral eous) l skin, warts leuk anogen lymphomas comprised of CD8þ T- and NK cells when cutan (HPV) nx, the Tax transgene was targeted to lymphocytes using epithia HPV genital T-cell sal, cervical, the lymphocyte-specific human granzyme B-promoter t ous virus and a ophary E7 [Hinrichs et al., 1987; Nerenberg et al., 1987; Grossman adul (muco or et al., 1995]. Although these studies provide strong Skin 8–10 8.0 Uterine dsDNA E6, Squam Common pillom (IM); evidence for the involvement of Tax in tumorigenesis, the pa sis exact mechanisms of Tax function have yet to be fully elucidated. Generally, it is believed that Tax promotes human ucleo and a a ); tumorigenesis by increasing genomic instability through incidence Asia Afric cells the disruption of normal host-cell processes, including monon (HBV V od B ran cellular transcription, DNA repair mechanisms, and cell Viruses high cirrhosis H , theast blo s, cycle progression. virus cytes, Sou B infectious in sub-Saha white ); itis Hepatiti 4 3.2 dsDNA HCC Common HBx Hepato Hepatocellular Carcinoma and HBV hepat /HAM Transforming HBV is a double-stranded DNA virus with a ubiquitous (TSP (ds). n, worldwide distribution. It is estimated that over 75% of LV-1); Asia thy the world’s population lives in regions of high infection ded merica, (HT Human A 1 M [Hollinger and Liang, 2001]. Similar to HTLV-1, HBV is elopa Caribbea e th theast HTLV-1 transmitted both horizontally through transfer of body le-stran my NA typ L P/HA Sou Sou cells pan, , T fluids and vertically from mother to child, and 70–90% of ted TS 6 ssR 9.0 Ja A Tax T- doub Common mothers chronically infected with HBV will pass the virus virus of (ss); on to their child, many of whom will become lifelong car- emia riers. Although the exact mechanism of vertical transmis- nt anded leuk age genes sion is not clear, virus-associated antigen has been found ll in cers of acid eases in amniotic fluid, cord blood, breast milk, and vaginal ing Properties gle-str T-ce dis can . (kB) nce tion esis/HTLV-1-associa I secretions, suggesting perinatal rather than transplacental sin E an tropism ze ucleic umber L transmission [Chen et al., 2004]. It has been estimated B infec N Si N A hum Prevale T Characteristic Genome Cell a Human Human Transform parapar (HD); that over 350 million people are chronic carriers of HBV 306 Gatza et al. and it is believed that over time the infection, potentially Uterine Cervical Cancer and HPV in combination with other environmental factors including aflatoxin B ingestion, cigarette smoking, and alcohol con- HPV is one of the most common sexually transmitted sumption, may result in the development of cirrhosis and diseases (STDs) worldwide and is believed to be the most HCC. In fact, it is currently believed that over 80% of all prevalent STD in the United States. Despite the fact that HCC cases are the result of infection by either HBV or genital HPV infection is not a reported disease, it is esti- hepatitis C virus (HCV) [Chen et al., 1997]. mated that between 1 and 5.5 million new cases occur each HCC is the fifth most frequently diagnosed cancer and year, and the overall prevalence of infection is greater than the fourth leading cause of cancer-related deaths 20 million people in the United States alone [Cates, 1999]. (> 500,000 annually) worldwide. Although the incidence HPV is most often transmitted by direct contact between rate in industrialized nations is rather low, due in part to two epithelial surfaces and is facilitated in part by the pre- immunization programs, HCC is the leading cause of can- sence of abrasions or lesions [Oriel, 1971; Moy et al., cer-related deaths among adults in Southeast Asia and 1989; Euvrard et al., 1993]. The incidence of HPV infec- sub-Saharan Africa. Worldwide, the mortality-to-incidence tion correlates directly with the number of sexual partners rate is close to or greater than 1, indicating that most an individual has encountered and infections are rare in patients will not survive longer than 1 year [Hollinger sexually inexperienced and/or young women [Rosenfeld and Liang, 2001].
Load more

Recommended publications
  • Rheumatoid Arthritis a Virus Disease?
    J Clin Pathol: first published as 10.1136/jcp.s3-12.1.132 on 1 January 1978. Downloaded from J. clin. Path., 31, Suppl. (Roy. Coll. Path.), 12, 132-143 Inflammation and fibrosis Rheumatoid arthritis a virus disease? A. M. DENMAN From the Division ofImmunological Medicine, Clinical Research Centre, Harrow, Middlesex We now understand many of the immunopatho- arteritis with perivascular infiltrates of chronic logical processes that damage joints and other inflammatory cells, and aberrant immune responses. structures in rheumatoid arthritis and diffuse con- Secondly, virus-infected cells initiate the whole nective tissue diseases. Unfortunately, our progress spectrum of inflammatory and immune reactions in this direction is matched by an equal failure to which characterise the human disorders. These identify the causes of all but a few of these disorders. include complement activation by the classical and Nevertheless, the stimuli which initiate these diseases alternative pathways, which in turn initiate such are probably commonly encountered and tissue processes as the immediate hypersensitivity reaction, damage results when these immunopathological platelet aggregation, and the chemotaxis of granulo- processes are abnormal in intensity and duration- cytes and mononuclear phagocytes. Furthermore, in other words, disease follows an unusual host virus-infected cells attract antibody either through reaction to a variety of environmental factors. This virus-coded antigens on the cell membrane or principle is well illustrated by the degenerative because infected cells commonly carry receptors for copyright. disease of the central nervous system, subacute the Fc portion of the immunoglobulin molecule. sclerosing panencephalitis, which ensues in in- These cells also attract a cellular response in the dividuals who are unable to control the growth form of both specifically sensitised T lymphocytes and dissemination of measles virus.
    [Show full text]
  • Barriers to Adoption of GM Crops
    Iowa State University Capstones, Theses and Creative Components Dissertations Fall 2021 Barriers to Adoption of GM Crops Madeline Esquivel Follow this and additional works at: https://lib.dr.iastate.edu/creativecomponents Part of the Agricultural Education Commons Recommended Citation Esquivel, Madeline, "Barriers to Adoption of GM Crops" (2021). Creative Components. 731. https://lib.dr.iastate.edu/creativecomponents/731 This Creative Component is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Creative Components by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Barriers to Adoption of GM Crops By Madeline M. Esquivel A Creative Component submitted to the Graduate Faculty in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Major: Plant Breeding Program of Study Committee: Walter Suza, Major Professor Thomas Lübberstedt Iowa State University Ames, Iowa 2021 1 Contents 1. Introduction ................................................................................................................................. 3 2. What is a Genetically Modified Organism?................................................................................ 9 2.1 The Development of Modern Varieties and Genetically Modified Crops .......................... 10 2.2 GM vs Traditional Breeding: How Are GM Crops Produced?
    [Show full text]
  • Human T-Cell Leukemia Virus Type I Tax Transactivates Human Interleukin 8 Gene Through Acting Concurrently on AP-1 and Nuclear Factor-KB-Like Sites
    [CANCER RESEARCH 58. 3993-4000. September 1. 1998] Human T-Cell Leukemia Virus Type I Tax Transactivates Human Interleukin 8 Gene through Acting Concurrently on AP-1 and Nuclear Factor-KB-like Sites Naoki Mori,1 Naofumi Mukaida, Dean W. Ballard, Kouji Matsushima, and Naoki Vaniamolo Department of Preventive Medicine and AIDS Research. Research Field of Palhogenesis and Clinical Sciences, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852, Japan ¡N.M.. N. YJ; Department of Pharmacology. Cancer Research Institute, Kanazawa University, Kanayiwa 920, Japan ¡N.M.¡:Department of Molecular Preventive Medicine, School of Medicine. University of Tok\o. Tokyo 113, Japan ¡K.M.I: and Howard Hughes Medical Institute. Vanderhilt University School of Medicine. Nashville, Tennessee 37232-0295 [D. W. BJ ABSTRACT unclear but could be one of the common pathological findings among diseases associated with HTLV-I infection. The transactivator protein, Tax, from the human T-cell leukemia virus IL-8 has potent chemotactic activity for T lymphocytes, as well as type I (HTLV-I) transactivates both viral and cellular genes. Previously, neutrophils (1, 2). Interestingly, T lymphocytes are 10-fold more we had shown that interleukin 8 (II.-8) is constitutively expressed in sensitive to IL-8 than neutrophils in chemotaxis (3). Thus, IL-8 is an HTLV-I-infected cells and in cells transiently expressing Tax. We show here that the II -X promoter is Tax responsive in Jurkat T cells. Further important mediator for tissue infiltration of various subsets of leuko more, using several deletion and mutated plasmids of the 5'-flanking cytes (7).
    [Show full text]
  • Interaction of Bovine Leukemia Virus Transactivator Tax with Bzip Proteins
    VIROLOGY 214, 207–214 (1995) Interaction of Bovine Leukemia Virus Transactivator Tax with bZip Proteins IMRE M. BOROS,1 FENG TIE, and CHOU-ZEN GIAM2 Division of Infectious Diseases, Department of Medicine, Case Western Reserve University, Cleveland, Ohio 44106 Received June 7, 1995; accepted October 2, 1995 The bovine leukemia virus transactivator, BLV Tax, augments transcription from three imperfect 21-bp repeats in the viral transcriptional regulatory region. Each BLV 21-bp repeat contains a cAMP response element (CRE) in the center and unique 5* and 3* neighboring sequences which are crucial for the transcriptional activation by BLV Tax. Here we describe the interactions of recombinant BLV Tax with cellular bZip proteins. The recombinant BLV Tax, tagged at the carboxy terminus with a hexahistidine extension, was prepared by solubilization in 6 M guanidine hydrochloride and renaturation on the Ni2/- chelating Sepharose gel matrix. The renatured BLV TaxH6 activates the BLV LTR when introduced into HeLa cells by scrape loading. Furthermore, the purified BLV TaxH6 enhances binding of members of the CREB/ATF family of bZip proteins to CRE motifs by interacting with their bZip domains in vitro. Chemical cross-linking indicates that dimerization of bZip proteins such as CREB becomes greatly facilitated in the presence of BLV Tax. These results suggest that BLV Tax interacts directly with CREB/ATF-like factors to activate viral mRNA transcription. q 1995 Academic Press, Inc. INTRODUCTION flanking the CRE dictate the exclusive inducibility of the 3 BLV or HTLV-I 21-bp repeats by the respective Tax pro- Bovine leukemia virus (BLV) and human T-lympho- teins (Fujisawa et al., 1989; Montagne et al., 1990; Paca tropic virus type I (HTLV-I) belong to a group of oncore- Uccaralertkun et al., 1994).
    [Show full text]
  • S12977-020-00538-W.Pdf
    Millen et al. Retrovirology (2020) 17:30 https://doi.org/10.1186/s12977-020-00538-w Retrovirology RESEARCH Open Access A novel positive feedback-loop between the HTLV-1 oncoprotein Tax and NF-κB activity in T-cells Sebastian Millen, Lina Meretuk, Tim Göttlicher, Sarah Schmitt, Bernhard Fleckenstein and Andrea K. Thoma‑Kress* Abstract Background: Human T‑cell leukemia virus type 1 (HTLV‑1) infects primarily CD4+ T‑lymphocytes and evoques severe diseases, predominantly Adult T‑Cell Leukemia/ Lymphoma (ATL/L) and HTLV‑1‑associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP). The viral transactivator of the pX region (Tax) is important for initiating malignant transformation, and deregulation of the major signaling pathway nuclear factor of kappa B (NF‑κB) by Tax represents a hallmark of HTLV‑1 driven cancer. Results: Here we found that Tax mutants which are defective in NF‑κB signaling showed diminished protein expres‑ sion levels compared to Tax wildtype in T‑cells, whereas Tax transcript levels were comparable. Strikingly, constant activation of NF‑κB signaling by the constitutive active mutant of inhibitor of kappa B kinase (IKK2, IKK‑β), IKK2‑EE, rescued protein expression of the NF‑κB defective Tax mutants M22 and K1‑10R and even increased protein levels of Tax wildtype in various T‑cell lines while Tax transcript levels were only slightly afected. Using several Tax expres‑ sion constructs, an increase of Tax protein occurred independent of Tax transcripts and independent of the promoter used. Further, Tax and M22 protein expression were strongly enhanced by 12‑O‑Tetradecanoylphorbol‑13‑Acetate [TPA; Phorbol 12‑myristate 13‑acetate (PMA)]/ ionomycin, inducers of NF‑κB and cytokine signaling, but not by tumor necrosis factor alpha (TNF‑α).
    [Show full text]
  • Chimeric Proteins Composed of Jun and CREB Define Domains
    JOURNAL OF VIROLOGY, Oct. 1995, p. 6209–6218 Vol. 69, No. 10 0022-538X/95/$04.0010 Copyright q 1995, American Society for Microbiology Chimeric Proteins Composed of Jun and CREB Define Domains Required for Interaction with the Human T-Cell Leukemia Virus Type 1 Tax Protein MIN JEAN YIN, EVYIND PAULSSEN, JACOB SEELER,† AND RICHARD B. GAYNOR* Departments of Internal Medicine and Microbiology, Divisions of Molecular Virology and Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, Texas 75235-8594 Received 5 April 1995/Accepted 26 June 1995 The regulation of human T-cell leukemia virus type 1 (HTLV-1) long terminal repeat gene expression is dependent on three cis-acting elements known as 21-bp repeats and the transactivator protein Tax. Mutagen- esis has demonstrated that sequences in each of the 21-bp repeats can be divided into three domains designated A, B, and C. Tax stimulates the binding of CREB to the B domain, which is essential for Tax activation of HTLV-1 gene expression. In this study, we demonstrate that Tax will stimulate the binding of CREB to the HTLV-1 21-bp repeats but does not stimulate CREB binding to the consensus cyclic AMP response element (CRE) element found in the somatostatin promoter. However, Tax stimulates CREB binding to a consensus CRE in the context of the 21-bp repeats, indicating the importance of these sequences in stimulating CREB binding. To determine the mechanism by which Tax stimulates CREB binding and determine potential interactions between Tax and CREB, we used the mammalian two-hybrid system in conjunction with in vitro binding and gel retardation assays.
    [Show full text]
  • The Internal Methionine Codons of Human T-Cellleukemia Virus Type
    JOURNAL OF VIROLOGY, Oct. 1990, p. 4914-4921 Vol. 64, No. 10 0022-538X/90/104914-08$02.00/0 Copyright C) 1990, American Society for Microbiology The Internal Methionine Codons of Human T-Cell Leukemia Virus Type II rex Gene Are Not Required for p24rex Production or Virus Replication and Transformation PATRICK L. GREEN,' YIMING XIE,' AND IRVIN S. Y. CHEN' 2* Division of Hematology-Oncology, Department of Medicine,' and Department of Microbiology and Immunology,2 UCLA School of Medicine and Jonsson Comprehensive Cancer Center, Los Angeles, California 90024-1736 Received 21 May 1990/Accepted 12 July 1990 Human T-cell leukemia virus types I (HTLV-I) and II (HTLV-II) have two nonstructural trans-acting regulatory genes, tax and rex, located in the 3' region of the viral genome. The tax gene product (HTLV-I p4O't and HTLV-II p37) is the transcriptional activator of the viral long terminal repeat. The rex gene encodes two protein products, p27rex/p2lrex and p26`ex/p24rex in HTLV-I and HTLV-II, respectively. Rex acts posttran- scriptionally to facilitate accumulation of full-length gaglpol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells. Previous studies showed that the first ATG of the rex gene is critical for Rex production and function. The importance of the internal ATGs to Rex function is not known. However, in vitro mutagenesis of the HTLV-I rex gene has provided indirect evidence which suggests that p2lrex, and by analogy HTLV-II p24rex, results from initiation at an internal AUG of the taxlrex mRNA.
    [Show full text]
  • Transcription Profile of Cells Infected with Human T-Cell Leukemia Virus Type I Compared with Activated Lymphocytes1
    [CANCER RESEARCH 62, 3562–3571, June 15, 2002] Transcription Profile of Cells Infected with Human T-cell Leukemia Virus Type I Compared with Activated Lymphocytes1 Cynthia A. Pise-Masison, Michael Radonovich, Renaud Mahieux, Pramita Chatterjee, Craig Whiteford, Janet Duvall, Claire Guillerm, Antoine Gessain, and John N. Brady2 Basic Research Laboratory, Virus Tumor Biology Section, National Cancer Institute, Bethesda, Maryland 20892 [C. A. P-M., M. R., P. C., J. D., C. G., J. N. B.]; Unite d’Epidemiologie et Physiopathologie des Virus Oncogenes, Batiment SIDA-Retrovirus, Institut Pasteur, 75724, Cedex 15, Paris, France [R. M., A. G.]; and Advanced Technology Center, National Institutes of Health, Gaithersburg, Maryland [C. W.] ABSTRACT vivo for viral infectivity and replication (12–16). In addition, the p12 protein has been implicated in the MHC class I-mediated immune Human T-cell leukemia virus type I (HTLV-I) is the etiologic agent for response and T-cell signaling (16–18). The viral protein p13 has also adult T-cell leukemia and the neurological disorder tropical spastic para- recently been reported to regulate cellular signaling pathways (19). -paresis/HTLV-I-associated myelopathy. CD4؉ T lymphocytes, the pri mary hosts for HTLV-I, undergo a series of changes that lead to T-cell Finally, the p30 protein is reported to play a role in transcriptional activation, immortalization, and transformation. To gain insight into the regulation with the use of Gal4-p30 fusion constructs (20). genetic differences between activated and HTLV-I-infected lymphocytes, DNA microarray technology has facilitated the development of a we performed Affymetrix GeneChip analysis of activated and HTLV-I- more complete and inclusive analysis of gene expression profiles in infected cells.
    [Show full text]
  • Prostate Cancer Chemoprevention Agents Exhibit Selective Activity Against Early Stage Prostate Cancer Cells
    Prostate Cancer and Prostatic Diseases (2001) 4, 81±91 ß 2001 Nature Publishing Group All rights reserved 1365±7852/01 $15.00 www.nature.com/pcan Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells YQ Liu1, E Kyle2, S Patel2, F Housseau3, F Hakim2, R Lieberman4, M Pins5, MV Blagosklonny2 & RC Bergan1* 1Division of Hematology/Oncology, Department of Medicine, Northwest University Medical School and the Robert H. Lurie Cancer Center of Northwestern University, Chicago, USA; 2Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, National Institutes, National Institutes USA; 3Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; 4Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; and 5Department of Pathology, Northwestern University Medical School and the Robert H. Lurie Cancer Center of Northwestern University, Chicago, USA Preclinical models for the identi®cation of prostate cancer chemoprevention agents are lacking. Based upon the notion that clinically useful chemoprevention agents should exhibit selective activity against early stage disease, studies were undertaken to assess whether chemoprevention agents selectively inhibited the growth of early stage prostate cancer, as compared to late stage cancer. First, a series of cell and molecular studies were performed, which, when taken together, validated the use of a panel of prostate cell lines as a model of the different stages of carcinogenesis. Next, therapeutic responsiveness to ten different cytotoxic or chemoprevention agents was evaluated. Chemoprevention agents exhibited selective activity against normal and early transformed prostate tissue, whereas cytotoxic agents were non-speci®c. Selective activity against early versus advanced prostate cancer cells is identi®ed as a potential screening method for chemoprevention agents.
    [Show full text]
  • Viral Transformation
    Proc. Natl. Acad. Sci. USA Vol. 75, No. 5, pp. 2473-2477, May 1978 Microbiology New region of the simian virus 40 genome required for efficient viral transformation (viable deletion mutants/soft agar assay/small t antigen) NOEL BOUCK*, NADINE BEALES*, THOMAS SHENK , PAUL BERGf, AND GIAMPIERO DI MAYORCA* * Department of Microbiology, University of Illinois at the Medical Center, Chicago, Illinois 60680; t Department of Microbiology, University of Connecticut Health Center, Farmington, Connecticut 06032; and * Department of Biochemistry, Stanford University Medical Center, Stanford, California 94305 Contributed by Paul Berg, February 13,1978 ABSTRACT Viable mutants of simian virus 40 with dele- deletions in the proximal part of the early region affect a dif- tions in three regions of the virus genome (map coordinates ferent function than the one altered in the ts A mutants. 0.21-0.17, 0.59-0.54, and 0.67-0.74) have been tested for their ability to transform rat fibroblasts to anchorage independence. MATERIALS AND METHODS Only those mutants whose deletions occur between 0.59 and 0.55 in the proximal part of the early region are defective in trans- Cells and Viruses. Fischer rat line Fill (15), kindly sent to forming ability. The most severely defective of these transform us by A. Freeman, and passaged less than 25 times, was used with less than one-hundredth the efficiency of wild type. They for most transformation experiments. Chinese hamster lung retain their defect when tested in Chinese hamster lung cells cells, CHL (7), were obtained from R. Martin. The monkey and when infection is initiated with viral DNA instead of intact line BSC-1 was used virions.
    [Show full text]
  • Wo 2008/048344 A2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) CORRECTED VERSION (19) World Intellectual Property Organization International Bureau (43) International Publication Date (10) International Publication Number 24 April 2008 (24.04.2008) PCT WO 2008/048344 A2 (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C12N 15/34 (2006.01) C12N 15/10 (2006.01) kind of national protection available): AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, (21) International Application Number: CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, PCT/US2007/003948 GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, (22) International Filing Date: JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, 13 February 2007 (13.02.2007) LT, LU, LV,LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, (25) Filing Language: English RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW (26) Publication Language: English (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 60/773,255 13 February 2006 (13.02.2006) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, (71) Applicant (for all designated States except US): FRAUN- ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), HOFER USA, INC.
    [Show full text]
  • 903, 943 Ff., 958 F., 1025 – Organismic 686 F
    1107 Index 14-3-3 108, 349 ff., 470 ff., 500, 529, 764 ff., AGC kinase 464 ff. 950 ff., 1057 agents – targeted 1079 a aging 17AAG (17-allylamino-17-demethoxygeld- – cellular 686 anamycin) 903, 943 ff., 958 f., 1025 – organismic 686 f. A20 108 AHA1 940 aberration AIDS 3, 67 – chromosomal 807 AIF (apoptosis inducing factor) 5, 205 ff., ACAMP, see apoptotic cell-associated 225 ff., 233 ff., 760, 850, 948 ff., 1059 molecular pattern – apoptotic function 238 acetylation 1015 ff. – cancer 249 acid sphingomyelinase (aSMase) 104, 997 f. – DNA fragmentation 246 actinomycin D 854 – down regulation 239 activation-induced cell death (AICD) – expression 234 10, 96 ff. – homolog 237 activin 495, 1099 – isoform 236 ACTR 1017 – release 241 acute myeloid leukemia (AML) 71, 419, – structure 234 917, 1018 AIF-homologous mitochondrion-associated acute promyelocytic leukemia 678, 1017 f. inducer of cell death (AMID), acyl-CoA-binding protein (ACBP) 210 see also p53-responsive gene 3 207, 237 adaptor protein (AP) AIF-like (AIFL) 207, 237 – AP-1 603 Akt, see protein kinase B – AP-2 603 aliphatic acids 1019 – AP-3 603 alkylating agent 799 – AP-4 603 alkylation therapy 842 adenine nucleotide translocator (ANT) alkyllysophospholipids (ALP) 1068 241, 286, 352, 578 alkylphosphocholines 1068 adenomatous polyposis alkyltransferase 799 – coli (APC) 176, 478 Alzheimerls disease 140 – familiarly adenomatous polyposis (FAP) aminopeptidase N (CD13) 112 syndrome 1073 aminophospholipid translocase 586 f. adenovirus amplification 164, 894, 973, 1018 – adenoviral gene transfer 903, 1035 AN-9 1026 – adenoviral vector-based system 852 anaplastic large cell lymphoma 678 – conditionally replicative 1035 androgen receptor (AR) 163 ff.
    [Show full text]